These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 29914576)
1. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. Srijiwangsa P; Ponnikorn S; Na-Bangchang K BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576 [TBL] [Abstract][Full Text] [Related]
2. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents. Zeekpudsa P; Kukongviriyapan V; Senggunprai L; Sripa B; Prawan A J Exp Clin Cancer Res; 2014 Jan; 33(1):11. PubMed ID: 24460787 [TBL] [Abstract][Full Text] [Related]
3. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells. Khunluck T; Kukongviriyapan V; Senggunprai L; Duangarsong W; Prawan A Integr Cancer Ther; 2019; 18():1534735418820444. PubMed ID: 30584780 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activities and effects of atractylodin and β-eudesmol on the cell cycle arrest and apoptosis on cholangiocarcinoma cell line. Kotawong K; Chaijaroenkul W; Muhamad P; Na-Bangchang K J Pharmacol Sci; 2018 Feb; 136(2):51-56. PubMed ID: 29525035 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory effect of β-eudesmol on cholangiocarcinoma cells and its potential suppressive effect on heme oxygenase-1 production, STAT1/3 activation, and NF-κB downregulation. Mathema VB; Chaijaroenkul W; Karbwang J; Na-Bangchang K Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1145-1154. PubMed ID: 28732110 [TBL] [Abstract][Full Text] [Related]
6. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588 [TBL] [Abstract][Full Text] [Related]
7. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway. Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773 [TBL] [Abstract][Full Text] [Related]
8. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521 [TBL] [Abstract][Full Text] [Related]
9. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents. Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836 [TBL] [Abstract][Full Text] [Related]
10. Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma. Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157 [TBL] [Abstract][Full Text] [Related]
11. Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model. Plengsuriyakarn T; Karbwang J; Na-Bangchang K Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):293-304. PubMed ID: 25545782 [TBL] [Abstract][Full Text] [Related]
12. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. Nutthasirikul N; Hahnvajanawong C; Techasen A; Limpaiboon T; Leelayuwat C; Chau-In S; Jearanaikoon P Int J Oncol; 2015 Dec; 47(6):2153-64. PubMed ID: 26459801 [TBL] [Abstract][Full Text] [Related]
13. Synergistic Effect of Forbesione From Garcinia hanburyi in Combination with 5-Fluorouracil on Cholangiocarcinoma. Boueroy P; Hahnvajanawong C; Boonmars T; Saensa-ard S; Wattanawongdon W; Kongsanthia C; Salao K; Wongwajana S; Anantachoke N; Reutrakul V Asian Pac J Cancer Prev; 2017 Dec; 18(12):3343-3351. PubMed ID: 29286229 [TBL] [Abstract][Full Text] [Related]
14. Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis. Sakonsinsiri C; Kaewlert W; Armartmuntree N; Thanan R; Pakdeechote P Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):28-33. PubMed ID: 30084792 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells. Seubwai W; Vaeteewoottacharn K; Kraiklang R; Umezawa K; Okada S; Wongkham S Oncol Res; 2016 Jan; 23(1-2):21-8. PubMed ID: 26802647 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells. Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189 [TBL] [Abstract][Full Text] [Related]
18. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells. Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan V Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):601-12. PubMed ID: 25708948 [TBL] [Abstract][Full Text] [Related]
19. Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acid. Maphanao P; Thanan R; Loilome W; Chio-Srichan S; Wongwattanakul M; Sakonsinsiri C Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129708. PubMed ID: 32810561 [TBL] [Abstract][Full Text] [Related]
20. The Proteomics and Metabolomics Analysis for Screening the Molecular Targets of Action of β-Eudesmol in Cholangiocarcinoma. Kotawong K; Chajaroenkul W; Roytrakul S; Phaonakrop N; Na-Bangchang K Asian Pac J Cancer Prev; 2021 Mar; 22(3):909-918. PubMed ID: 33773557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]